Aaron Lazorwitz
Overview
Explore the profile of Aaron Lazorwitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
79
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lazorwitz A, Sheeder J, Teal S
Contraception
. 2024 Jul;
140:110539.
PMID: 39002624
Objective: To evaluate how diet, exercise, and substance use influence serum etonogestrel concentrations among contraceptive implant users. Study Design: We conducted a cross-sectional analysis of healthy, reproductive-age etonogestrel implant users....
2.
Kendall P, Bresnitz W, Huang J, Sheeder J, Lazorwitz A
Contraception
. 2024 May;
137:110486.
PMID: 38754757
Objective: To identify factors associated with the need for a deep etonogestrel contraceptive implant removal as compared to superficial removal. Study Design: We conducted a retrospective cohort study of patients...
3.
Masten M, Sheeder J, Lazorwitz A
Cureus
. 2024 Apr;
16(3):e57034.
PMID: 38681459
Objectives: To evaluate how recent opioid, marijuana, and cannabidiol use affects pre-procedure pain-related anxiety for patients seeking abortion. Methods: We conducted a prospective, cross-sectional anonymous survey of patients seeking abortion...
4.
Clure C, Sheeder J, Lazorwitz A
Contraception
. 2024 Mar;
135:110442.
PMID: 38552822
Objectives: To assess the pharmacokinetics and pharmacodynamics of the etonogestrel (ENG) contraceptive implant when inserted at an alternative scapular site. Study Design: We conducted a pilot study of healthy, reproductive-age...
5.
Friedman J, Sheeder J, Polotsky A, Lazorwitz A
J Pediatr Adolesc Gynecol
. 2023 Dec;
37(3):323-329.
PMID: 38061680
Study Objective: We aimed to evaluate herbal medicine and supplement use patterns among adolescent and young adult women at a clinic focused on family planning. Methods: We conducted a cross-sectional...
6.
Drake E, Larrea N, Wolverton E, Tibbits B, Lazorwitz A, Schultz C
Obstet Gynecol
. 2023 Oct;
142(6):1455-1458.
PMID: 37884025
Posttraumatic stress disorder (PTSD) is underdiagnosed peripartum. We administered a primary care screening tool and a pregnancy-related PTSD screening tool to postpartum patients presenting to our urban safety-net institution within...
7.
Diamond B, Sheeder J, Lazorwitz A
Contraception
. 2023 Oct;
129:110298.
PMID: 37802462
Objective: To evaluate if inter-individual variability in serum etonogestrel (ENG) concentrations accounts for variability in mood-related side effects among ENG implant users. Study Design: Participants underwent a single-time blood draw...
8.
Lazorwitz A, Sheeder J
Contraception
. 2023 Jun;
126:110093.
PMID: 37331464
Objectives: To confirm that 24-hour steady-state trough measurements (C) are high-quality proxies for gold standard pharmacokinetic measurements (area under the curve [AUC]) of a combined oral contraceptive pill (COCP). Study...
9.
Lazorwitz A, Sheeder J, Teal S
Contraception
. 2023 Mar;
123:110035.
PMID: 36997081
Objectives: Rifampin, a strong CYP3A inducer, is the gold standard for evaluating CYP3A-mediated drug-drug interactions. We aimed to evaluate the pharmacokinetic and pharmacodynamic effects of a short course (2 weeks)...
10.
Friedman J, Sheeder J, Lazorwitz A, Polotsky A
F S Rep
. 2023 Mar;
4(1):104-111.
PMID: 36959959
Objective: To address the knowledge gap surrounding herbal medicine and supplement usage patterns and supplement-prescription medication interactions among patients seeking treatment for infertility. Design: Cross-sectional survey study. Setting: Academic infertility...